The RNA Production Facility is now fully operational and has begun supporting critical research efforts across the country. Managed by our experienced Production Leads, Dr. Rebecca McKenzie and Dr. Sarah Draper. The facility is well positioned as a central hub for RNA technology that will produce research-grade RNA, encapsulated where required, enabling research and development across the country, while simultaneously advancing the development and refinement of manufacturing techniques for various RNA products.
Currently, the facility's team is focused on producing messenger RNA (mRNA) and antisense oligonucleotides (ASOs), which are encapsulated in lipid nanoparticles (LNPs) to ensure optimal delivery for research applications. The first 50 samples have already been distributed to several Fast Start projects funded by the Platform, providing a crucial resource for early-stage research.
As more research projects are initiated, the facility aims to expand its capabilities. Our goal is to equip the central facility with the knowledge and skills necessary to handle a broader range of RNA modalities, supporting researchers across the motu in advancing RNA-based technologies.